The Other Marijuana Takes Off

Something unexpected is happening in Oregon. In an effort to make more money from medical marijuana, they have stopped growing marijuana. Instead, they’re growing its nonintoxicating cousin, hemp. Good old boring hemp, mostly known for being used to make ropes, textiles, and paper. So what gives? Why abandon producing recreational drugs to ship to trendy, bougie Portland shops in favor of a You are receiving this email because you subscribed to Outsider Club. [Click here]( to manage your e-mail preferences. [Outsider Club logo] The Other Marijuana Takes Off [Adam English Photo] By [Adam English]( Written May. 16, 2018 Something unexpected is happening in Oregon. In an effort to make more money from medical marijuana, they have stopped growing marijuana. Instead, they’re growing its nonintoxicating cousin, hemp. Good old boring hemp, mostly known for being used to make ropes, textiles, and paper. So what gives? Why abandon producing recreational drugs to ship to trendy, bougie Portland shops in favor of a plant that gets turned into rope that costs $0.50 per foot on Amazon? A couple factors are at play here, but the underlying reason is simple: It’s all about profit. And as the marijuana sector, especially medical marijuana sales, continues to grow and mature, we will be seeing more marijuana growers in more states transitioning to hemp in the near future. "...capable of turning every $1,000 invested into $114,000." Live Demo! Time tested trading system capable of turning every $1,000 into $114,000 to be revealed in a special live Internet broadcast. It's free to watch, but seats are limited. [Reserve yours today.]( Why Oregon? Oregon is swimming in marijuana and the glut of production is driving marijuana prices sharply down in the state. According to the Oregon Office of Economic Analysis, the price per gram of marijuana has fallen 50%, from $14 to $7, since 2015. Unlike other states, Oregon did not cap the number of growing licenses it issued. Yet growers are unable to export marijuana without running afoul of federal law. Roughly 1 million pounds of flower, and 350,000 pounds of extracts, edibles, and tinctures were produced last year. That is far more than the state will consume, and growers are being pinched by the low prices and difficulty selling everything they produce into the market. As Trey Willison, a marijuana grower who switched his operation to hemp this season, told AP News: “Now we’re starting to look at drastic means, like destroying product. At some point, there’s no more storage for it. Whoever would have thought we’d get to the point of destroying pounds of marijuana?” [$50 Into $1,200,000]( If you had put $50 into Pfizer stock at its IPO, you’d be a millionaire. You’re about to discover the “Next Pfizer”, which recently IPO’d. I’ve visited restricted areas of this company and grilled the CEO personally. This company is disrupting a $635 billion industry. And it trades for a couple bucks... Here’s your shot to 10X your money. [Click here to see the company.]( The New Hot Product In Oregon, the number of hemp licenses increased from 12 in 2015 to 353 as of last week. Growers are chasing the kinds of returns they expected going into the business, and hemp’s potential for out-of-state sales is supporting prices in one of the most promising aspects of medical marijuana. Hemp is just as good, if not better, for an extract called cannabidiol, or CBD. And while the marijuana is being used to produce some of it, CBD from hemp has a distinct advantage. Growing industrial hemp is legal under federal law, and CBD production can drive sales from growing hemp to over $100,000 per acre, with each kilogram of CBD selling for thousands of dollars. Mr. Willison, quoted above, extracts the CBD from his own hemp and can sell it for up to $13,000 per kilogram. Compare that to $7,000 per kilogram of marijuana at retail, a price that growers receive a fraction of, and you can see why the change is underway. At this point it is estimated that 50% of the hemp grown nationwide is being used to produce CBD. That CBD is popping up on a long list of consumer products, from edibles, bottled water, and pet treats to cosmetics, skin creams, and transdermal patches. [Footage reveals America’s biggest gold mine... NOT yet public knowledge]( [nick midas 2](I recently put my boots on the ground at a remote site in Idaho... a place not accessible by typical transportation. And what I discovered has blown away anything I’ve seen in my decade in the gold and resource sectors. This mine is the single biggest in America. Not second or third... but #1. And absolutely NOBODY knows about it. That will all change soon, thanks to a shocking announcement that will launch one 75-cent gold miner to unprecedented new heights. [Click here for the full story.]( Medical Marijuana (kind of) For Everyone The reasons for soaring CBD consumer demand are pretty straightforward. You can get many of the benefits of medical marijuana without the accompanying high that marijuana is known for. Hemp contains virtually no THC, the intoxicating chemical that marijuana crops have largely been designed to maximize. While CBD extracted from marijuana will contain virtually no THC, it still puts many in a quandary. Some people operate vehicles or machinery for a living, or their employment contracts strictly forbid drug use, or they simply don’t want to support recreational marijuana use. Then there are more specialized concerns. CBD greatly reduces epileptic seizures, especially for a rare form called Dravet syndrome that affects young children, causing development delays, neurological damage, and 20% of sufferers to die before they are 20. Parents may not like the idea of giving their children medical marijuana, but a hemp extract is far more palatable. Pre-clinical studies of CBD have shown promise for treatment of chronic pain, neuroinflammation, anxiety, addiction, Multiple Sclerosis, PTSD, cancer and cancer medication side effects, Alzheimer’s, Crohn’s disease, and it shows anti-psychotic effects. Of all of those symptoms, chronic pain management is clearly the elephant in the room, with all the problems it has caused in recent years and the $635 billion in pharmaceutical sales it drives. With the ongoing opioid crisis in the U.S., we desperately need effective alternatives that reduce prescriptions while lessening the risk of addiction and harmful side effects. [CBD fits the bill](, and as its popularity grows, there is no clearer target for CBD producers than the $635 billion pain industry. Demand is soaring, and CBD production from hemp is as well. [Now is the time to grab your share of the profits](. Take care, [Adam English] Adam English [follow basic]( [@AdamEnglishOC on Twitter]( Adam's editorial talents and analysis drew the attention of senior editors at [Outsider Club](, which he joined in mid-2012. While he has acquired years of hands-on experience in the editorial room by working side by side with ex-brokers, options floor traders, and financial advisors, he is acutely aware of the challenges faced by retail investors after starting at the ground floor in the financial publishing field. For more on Adam, check out his editor's [page](. *Follow Outsider Club on [Facebook]( and [Twitter](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Check Out This Prospect Generator (ticker included)]( [Hidden Earnings Punishment]( [A Major Player Just Bought Into America’s Biggest Gold Mine]( [The Time is Now]( [Drilling For Copper At A Breakneck Pace]( Related Articles [Scientific Support for Medical Cannabis Soars]( [Trump Phone Call Sends Pot Stocks Flying]( [Marijuana 2.0]( [The Time is Now]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2018, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.